Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
2.670
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Spero Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 155 | 131 | 56 | 78 | 90 | 518 | |
| Market Cap Growth | 361.40% | 133.77% | -27.92% | -13.02% | -82.69% | -1.83% | |
| Enterprise Value | 117 | 86 | -16 | -10 | 46 | 401 | |
| Last Close Price | 2.67 | 2.33 | 1.03 | 1.47 | 1.73 | 16.01 | |
| PE Ratio | 17.80 | 15.31 | - | 3.42 | - | - | |
| Forward PE | 3.99 | 4.88 | - | - | - | - | |
| PS Ratio | 2.31 | 1.97 | 1.17 | 0.75 | 1.67 | 28.35 | |
| PB Ratio | 2.55 | 2.22 | 1.22 | 0.73 | 1.18 | 5.86 | |
| P/TBV Ratio | 2.62 | 2.22 | 1.22 | 0.73 | 1.18 | 5.86 | |
| EV/Sales Ratio | 1.75 | 1.29 | - | - | 0.86 | 21.98 | |
| EV/EBITDA Ratio | 16.37 | 12.01 | - | - | - | - | |
| EV/EBIT Ratio | 16.37 | 12.01 | - | - | - | - | |
| Debt / Equity Ratio | 0.05 | 0.05 | 0.09 | 0.05 | 0.09 | 0.63 | |
| Debt / EBITDA Ratio | 0.34 | 0.34 | - | 0.19 | - | - | |
| Net Debt / Equity Ratio | -0.63 | -0.63 | -1.05 | -0.66 | -1.35 | -1.03 | |
| Net Debt / EBITDA Ratio | -5.22 | -5.22 | 0.67 | -2.61 | 3.45 | 1.04 | |
| Net Debt / FCF Ratio | 2.96 | 2.96 | 2.07 | 2.15 | 13.25 | 1.41 | |
| Asset Turnover | 0.74 | 0.74 | 0.33 | 0.68 | 0.36 | 0.11 | |
| Quick Ratio | 7.40 | 7.40 | 2.15 | 3.42 | 5.09 | 7.98 | |
| Current Ratio | 7.59 | 7.59 | 2.19 | 3.53 | 5.25 | 8.46 | |
| Return on Equity (ROE) | 16.30% | 16.30% | -89.62% | 24.95% | -56.53% | -81.47% | |
| Return on Assets (ROA) | 4.99% | 4.99% | -30.93% | 10.90% | -12.91% | -33.88% | |
| Return on Invested Capital (ROIC) | 482.46% | 72.44% | -431.00% | 502.14% | - | -1658.58% | |
| Return on Capital Employed (ROCE) | 11.90% | 11.90% | -117.90% | 18.40% | -29.60% | -57.70% | |
| Earnings Yield | 5.55% | 6.53% | -122.10% | 29.27% | -51.82% | -17.34% | |
| FCF Yield | -8.17% | -9.62% | -41.75% | -42.35% | -8.63% | -12.43% | |
| Buyback Yield / Dilution | -9.26% | -9.25% | -1.98% | -40.98% | -21.65% | -38.01% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.